Clinical Trial Update: Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial assessing thalidomide, dexamethasone, and clarithromycin in patients with multiple myeloma previously treated with transplant; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma | Phase 2 | Status: COMPLETED